Skip to main content
Foreword
Welcome to Volume 5 of the Journal of Comparative Effectiveness Research
- Laura Dormer
pp1–3
Published Online:23 December 2015
Editorial
Use of androgen receptor signaling-targeted therapies in chemotherapy-naive metastatic castration-resistant prostate cancer: a call for patient-centered studies
- Won Kim and
- Charles J Ryan
pp5–7
Published Online:21 December 2015
From Methods to Policy
Cost–effectiveness thresholds in the USA: are they coming? Are they already here?
- Robert W Dubois
pp9–12
Published Online:21 December 2015
Interview
Using design methods to provide the care that people want and need
- Kim Erwin and
- Jerry A Krishnan
pp13–15
Published Online:23 December 2015
Research Article
Engaging stakeholders to design a comparative effectiveness trial in children with uncontrolled asthma
- Kim Erwin,
- Molly A Martin,
- Tara Flippin,
- Sarah Norell,
- Ariana Shadlyn,
- Jie Yang,
- Paula Falco,
- Jaime Rivera,
- Stacy Ignoffo,
- Rajesh Kumar,
- Helen Margellos-Anast,
- Michael McDermott,
- Kate McMahon,
- Giselle Mosnaim,
- Sharmilee M Nyenhuis,
- Valerie G Press,
- Jessica E Ramsay,
- Kenneth Soyemi,
- Trevonne M Thompson, and
- Jerry A Krishnan
pp17–30
Published Online:21 December 2015
- This article corrects the following:
Corrigendum
- Volume 5Issue 2Journal of Comparative Effectiveness Research
- 8 February 2016
Comparing safety of heparin as continuous intravenous infusion and multiple subcutaneous injections
- Mandana Izadpanah,
- Hossein Khalili, and
- Mostafa Mohammadi
pp31–38
Published Online:21 December 2015
Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis
- Kathleen Lang,
- Victoria Federico,
- Aarti A Patel,
- Michael Munsell,
- Winnie W Nelson,
- Gary Owens,
- Samir H Mody,
- Jeffery Schein, and
- Joseph Menzin
pp39–48
Published Online:21 December 2015
Social and private benefits of assisted reproductive technology: a national survey-based evaluation in Israel
- Limor Dina Gonen
pp49–63
Published Online:23 December 2015
RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
- Anne L Coleman,
- Flora C Lum,
- Priscilla Velentgas,
- Daniel Campion,
- Zhaohui Su,
- Richard E Gliklich, and
- for the RiGOR Study Group
pp65–78
Published Online:22 December 2015
Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
- Anne L Coleman,
- Flora C Lum,
- Priscilla Velentgas,
- Zhaohui Su,
- Richard E Gliklich, and
- for the RiGOR Study Group
pp79–85
Published Online:22 December 2015
Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
- Anne L Coleman,
- Flora C Lum,
- Priscilla Velentgas,
- Zhaohui Su,
- Richard E Gliklich, and
- the RiGOR Study Group
pp87–98
Published Online:22 December 2015
Quality of life and visual acuity outcomes in the Registry in Glaucoma Outcomes Research study
- Anne L Coleman,
- Flora C Lum,
- Richard E Gliklich,
- Priscilla Velentgas,
- Zhaohui Su, and
- RiGOR Study Group
pp99–111
Published Online:22 December 2015